BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16191191)

  • 1. Biochemical characterization of Cdk2-Speedy/Ringo A2.
    Cheng A; Gerry S; Kaldis P; Solomon MJ
    BMC Biochem; 2005 Sep; 6():19. PubMed ID: 16191191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins.
    Cheng A; Xiong W; Ferrell JE; Solomon MJ
    Cell Cycle; 2005 Jan; 4(1):155-65. PubMed ID: 15611625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RINGO/Speedy proteins, a family of non-canonical activators of CDK1 and CDK2.
    Gonzalez L; Nebreda AR
    Semin Cell Dev Biol; 2020 Nov; 107():21-27. PubMed ID: 32317145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins.
    Karaiskou A; Perez LH; Ferby I; Ozon R; Jessus C; Nebreda AR
    J Biol Chem; 2001 Sep; 276(38):36028-34. PubMed ID: 11461916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK activation by non-cyclin proteins.
    Nebreda AR
    Curr Opin Cell Biol; 2006 Apr; 18(2):192-8. PubMed ID: 16488127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of cell-cycle progression by RINGO/Speedy E.
    Dinarina A; Ruiz EJ; O'Loghlen A; Mouron S; Perez L; Nebreda AR
    Biochem J; 2008 Mar; 410(3):535-42. PubMed ID: 18072937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new family of cyclin-dependent kinase activators.
    Dinarina A; Perez LH; Davila A; Schwab M; Hunt T; Nebreda AR
    Biochem J; 2005 Mar; 386(Pt 2):349-55. PubMed ID: 15574121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meiotic inactivation of Xenopus Myt1 by CDK/XRINGO, but not CDK/cyclin, via site-specific phosphorylation.
    Ruiz EJ; Hunt T; Nebreda AR
    Mol Cell; 2008 Oct; 32(2):210-20. PubMed ID: 18951089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New structural insights into phosphorylation-free mechanism for full cyclin-dependent kinase (CDK)-cyclin activity and substrate recognition.
    Zheng F; Quiocho FA
    J Biol Chem; 2013 Oct; 288(42):30682-30692. PubMed ID: 24022486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle regulation of the mammalian CDK activator RINGO/Speedy A.
    Dinarina A; Santamaria PG; Nebreda AR
    FEBS Lett; 2009 Sep; 583(17):2772-8. PubMed ID: 19622356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.
    McGrath DA; Fifield BA; Marceau AH; Tripathi S; Porter LA; Rubin SM
    EMBO J; 2017 Aug; 36(15):2251-2262. PubMed ID: 28666995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speedy/Ringo C regulates S and G2 phase progression in human cells.
    Cheng A; Solomon MJ
    Cell Cycle; 2008 Oct; 7(19):3037-47. PubMed ID: 18802405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin B and cyclin A confer different substrate recognition properties on CDK2.
    Brown NR; Lowe ED; Petri E; Skamnaki V; Antrobus R; Johnson LN
    Cell Cycle; 2007 Jun; 6(11):1350-9. PubMed ID: 17495531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Speedy/RINGO Protein in Breast Cancer as a Future Biomarker.
    Tanriverdi O; Yildiz A
    Cancer Diagn Progn; 2024; 4(3):209-213. PubMed ID: 38707716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15.
    Sebastian B; Kakizuka A; Hunter T
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3521-4. PubMed ID: 8475101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the Cdk-activator Speedy/RINGO in vertebrates.
    Chauhan S; Zheng X; Tan YY; Tay BH; Lim S; Venkatesh B; Kaldis P
    Cell Mol Life Sci; 2012 Nov; 69(22):3835-50. PubMed ID: 22763696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential phosphorylation patterns between the Cyclin-A2/CDK2 complex and their monomers.
    Casado-Vela J; Martínez-Torrecuadrada JL; Casal JI
    Protein Expr Purif; 2009 Jul; 66(1):15-21. PubMed ID: 19233286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity.
    Horton LE; Templeton DJ
    Oncogene; 1997 Jan; 14(4):491-8. PubMed ID: 9053846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
    Upton JW; van Dyk LF; Speck SH
    Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.